Lemonade, Inc. (NYSE:LMND - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Lemonade in a research report issued to clients and investors on Wednesday, August 13th. Cantor Fitzgerald analyst R. Tunis expects that the company will earn ($2.62) per share for the year. Cantor Fitzgerald currently has a "Strong-Buy" rating on the stock. The consensus estimate for Lemonade's current full-year earnings is ($3.03) per share. Cantor Fitzgerald also issued estimates for Lemonade's FY2026 earnings at ($1.25) EPS.
Lemonade (NYSE:LMND - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.60) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.81) by $0.21. The firm had revenue of $164.10 million during the quarter, compared to the consensus estimate of $160.88 million. Lemonade had a negative return on equity of 36.12% and a negative net margin of 33.96%. The business's revenue for the quarter was up 34.5% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.81) EPS.
LMND has been the subject of several other research reports. Wall Street Zen raised shares of Lemonade from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. Morgan Stanley reiterated an "underweight" rating and set a $26.00 price target (up previously from $24.00) on shares of Lemonade in a research report on Monday, July 14th. BMO Capital Markets lifted their price target on Lemonade from $15.00 to $23.00 and gave the company an "underperform" rating in a research report on Wednesday, July 2nd. Keefe, Bruyette & Woods reiterated an "underperform" rating and set a $26.00 price target (up previously from $22.00) on shares of Lemonade in a research report on Tuesday, July 1st. Finally, Piper Sandler reiterated a "neutral" rating and set a $55.00 price target on shares of Lemonade in a research report on Thursday. Four research analysts have rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Lemonade has an average rating of "Hold" and a consensus target price of $37.71.
Get Our Latest Stock Report on LMND
Lemonade Stock Performance
NYSE LMND traded down $1.48 during trading hours on Friday, hitting $57.04. The company had a trading volume of 180,862 shares, compared to its average volume of 2,339,816. Lemonade has a 52 week low of $15.27 and a 52 week high of $60.41. The firm has a 50 day simple moving average of $42.76 and a 200 day simple moving average of $35.92. The firm has a market capitalization of $4.21 billion, a price-to-earnings ratio of -20.30 and a beta of 2.19.
Insider Activity
In other Lemonade news, COO Adina Eckstein sold 5,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $49.00, for a total transaction of $245,000.00. Following the completion of the sale, the chief operating officer directly owned 189,653 shares of the company's stock, valued at $9,292,997. This trade represents a 2.57% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider John Sheldon Peters sold 6,543 shares of Lemonade stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $45.00, for a total value of $294,435.00. Following the completion of the sale, the insider directly owned 106,115 shares in the company, valued at approximately $4,775,175. The trade was a 5.81% decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,289 shares of company stock worth $825,982 in the last ninety days. Corporate insiders own 14.70% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. The Manufacturers Life Insurance Company grew its position in Lemonade by 7.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 31,000 shares of the company's stock valued at $1,137,000 after acquiring an additional 2,209 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Lemonade by 14.0% during the 4th quarter. Invesco Ltd. now owns 76,718 shares of the company's stock worth $2,814,000 after purchasing an additional 9,419 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Lemonade by 35,901.8% during the 1st quarter. GAMMA Investing LLC now owns 19,801 shares of the company's stock worth $630,000 after purchasing an additional 19,746 shares during the last quarter. Northern Trust Corp grew its stake in shares of Lemonade by 23.7% during the fourth quarter. Northern Trust Corp now owns 562,502 shares of the company's stock worth $20,633,000 after acquiring an additional 107,592 shares during the last quarter. Finally, Halter Ferguson Financial Inc. grew its stake in shares of Lemonade by 62.8% during the first quarter. Halter Ferguson Financial Inc. now owns 476,764 shares of the company's stock worth $14,985,000 after acquiring an additional 183,974 shares during the last quarter. 80.30% of the stock is owned by hedge funds and other institutional investors.
About Lemonade
(
Get Free Report)
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lemonade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.
While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.